Ticker: ABBV | Published: 2026-09-23
ABBV drifts up quietly
AbbVie is grinding higher on low volatility after EU approval for RINVOQ in pediatric arthritis, a modestly positive but incremental regulatory win that lacks the force to spark a big move, while the healthcare sector lags a strong tech-led tape.
Sources: https://finance.yahoo.com/healthcare/articles/abbvie-abbv-won-eu-approval-091344949.html, https://www.i